An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants

Summary

The purpose of this study is to investigate the effect of taking multiple doses of BMS-986177 when aspirin is taken once-daily. Eligible participants will receive twice-daily doses of BMS-986177 or placebo, with a once-daily dose of aspirin. The safety, tolerability and movement of BMS-986177 into, through and out of the body (pharmacokinetics/PK) will be assessed, as will the effect of BMS-986177 on the PK of aspirin.

Timeline

Start

2017-10-18

Primary completion

2017-11-16

Completion

2017-11-16

Drugs

Indications

No indication recorded.